Literature DB >> 19467284

Involvement of Sema4D in the control of microglia activation.

Marcia Toguchi1, Daniel Gonzalez, Sohei Furukawa, Shinobu Inagaki.   

Abstract

Microglia normally exist in a resting state characterized by a ramified morphology, and are responsible for immune surveillance in the CNS. However, the resting microglia rapidly transform towards an activated phenotype in response to brain injury or immunological stimuli. In certain pathological conditions, the unregulated response or over-activation of microglia can provoke severe neuronal damage. Here, we have investigated whether Semaphorin4D (Sema4D/CD100) could function as a potential factor to control activation. Microglia were cultured, activated by bacterial endotoxin lipopolysaccharide (LPS) and then, exposed to Sema4D/CD100 or conditioned medium. We found that Sema4D/CD100 negatively controlled LPS-induced morphological activation. Moreover, intracerebral injection of LPS-induced abundant microglial activated forms in mice lacking Sema4D/CD100. Sema4D/CD100 also inhibited other relevant aspects of cell activation. Treatment with Sema4D/CD100 inhibited the production of nitrites and LPS-induced microglia migration. We also provide evidence that LPS markedly upregulated Plexin-B1 expression in microglia and Sema4D/CD100 stimulated RhoA-activation in LPS-activated microglia. Taken together, these findings suggest a novel role of Sema4D/CD100 in the regulation of microglia activation providing a valuable neuroprotective tool to the CNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467284     DOI: 10.1016/j.neuint.2009.05.013

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

Review 1.  Targets for neural repair therapies after stroke.

Authors:  S Thomas Carmichael
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 2.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 3.  Transmembrane semaphorins: Multimodal signaling cues in development and cancer.

Authors:  Sreeharsha Gurrapu; Luca Tamagnone
Journal:  Cell Adh Migr       Date:  2016-06-13       Impact factor: 3.405

4.  Neuroprotective dobutamine treatment upregulates superoxide dismutase 3, anti-oxidant and survival genes and attenuates genes mediating inflammation.

Authors:  Tina Markus; David Ley; Stefan R Hansson; Tadeusz Wieloch; Karsten Ruscher
Journal:  BMC Neurosci       Date:  2018-03-09       Impact factor: 3.288

Review 5.  Role of Semaphorins in Ischemic Stroke.

Authors:  Huaping Du; Yuan Xu; Li Zhu
Journal:  Front Mol Neurosci       Date:  2022-03-08       Impact factor: 5.639

6.  Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity.

Authors:  Elizabeth E Evans; Vikas Mishra; Crystal Mallow; Elaine M Gersz; Leslie Balch; Alan Howell; Christine Reilly; Ernest S Smith; Terrence L Fisher; Maurice Zauderer
Journal:  J Neuroinflammation       Date:  2022-08-06       Impact factor: 9.587

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.